A Systematic Review and Meta-Analysis Assessing the Relative Efficacy of Immune Checkpoint Inhibitors Based on PD-L1 Expression Levels
Indiana University-Purdue University Indianapolis (IUPUI) === Purpose: The purpose was to comprehensively assess the impact of PD-L1 expression on the efficacy of immune checkpoint inhibitors on Overall Survival (OS) and Progression-Free Survival (PFS). Methods: A systematic literature search and r...
Main Author: | Kwiatkowski, Kathy |
---|---|
Other Authors: | Han, Jiali |
Language: | en_US |
Published: |
2020
|
Subjects: | |
Online Access: | http://hdl.handle.net/1805/24615 |
Similar Items
-
A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
by: Fan Z, et al.
Published: (2019-03-01) -
Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
by: Shuai Wang, et al.
Published: (2018-08-01) -
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
by: Koji Haratani, et al.
Published: (2020-04-01) -
Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
by: Kübra KAHVECİ, et al.
Published: (2019-12-01) -
The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
by: Lihu Gu, et al.
Published: (2019-06-01)